NBRV News and Press, Nabriva Therapeutics plc From 03/01/21

Athenex (ATNX) -55% on Q4 earnings release and on FDA rejection of oral paclitaxel application in breast cancer.Xtant Medical Holdings (XTNT) -16%.PLx Pharma (PLXP) -9% after FDA OKs PLx Pharma's Vazalore applications.Lixte Biotechnology Holdings (LIXT) -12%.Amer...

DUBLIN, Ireland and KING OF PRUSSIA, Pa., March 01, 2021 (GLOBE NEWSWIRE) -- Nabriva Therapeutics plc (NASDAQ: NBRV), a biopharmaceutical company engaged in the commercialization and development of innovative anti-infective agents to treat serious infections, today announced that it ha...

Nabriva Therapeutics (NBRV) names Daniel Dolan as Chief Financial Officer, effective close of business March 12, 2021.Dolan will replace current CFO Gary Sender, who is retiring from Nabriva. Sender will serve as a consultant for Nabriva at least through the remainder...

DUBLIN, Ireland and KING OF PRUSSIA, Pa., Feb. 26, 2021 (GLOBE NEWSWIRE) -- Nabriva Therapeutics plc (NASDAQ: NBRV), a biopharmaceutical company engaged in the commercialization and development of innovative anti-infective agents to treat serious infections, today announced the appointment ...

Contemporary data demonstrate macrolide resistance in S. pneumoniae is 39.5 percent overall and greater than 25 percent in most regions of the country Macrolide resistance shown to be significantly more common in outpatients vs. inpatients, with rates as high as 45.3 percent vs. 3...

UTILITY Therapeutics Joins Antimicrobials Working Group PR Newswire WASHINGTON , Feb. 17, 2021 /PRNewswire/ -- The Antimicrobials Working Group (AWG) announced today the addition of UTILITY therapeutics Ltd. (UTILITY) to its coalition of companies with the missio...

Are Cheap Stocks Worth The Risk? In this article, I’ll go over a few things. First, what is a penny stock ? Next, I’ll touch on some basic rules of thumb many traders use to consistently profit. Finally, we’ll look at a few “cheap” stocks that are ...

Biopharmaceutical company Nabriva Therapeutics (NBRV) announces the retirement of Gary Sender from the role of Chief Financial Officer ((CFO)), effective March 12, 2021.Sender has agreed to serve as a consultant for Nabriva on an ongoing basis following his retirement to e...

DUBLIN, Ireland and KING OF PRUSSIA, Pa., Feb. 01, 2021 (GLOBE NEWSWIRE) -- Nabriva Therapeutics plc (NASDAQ: NBRV), a biopharmaceutical company engaged in the commercialization and development of innovative anti-infective agents to treat serious infections, today announced the retirement o...

DUBLIN, Ireland and KING OF PRUSSIA, Pa., Jan. 05, 2021 (GLOBE NEWSWIRE) -- Nabriva Therapeutics plc (NASDAQ: NBRV), a biopharmaceutical company engaged in the commercialization and development of innovative anti-infective agents to treat serious infections, today announced that management ...